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Avaliação da satisfação sexual em pacientes portadoras de fibromialgia
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Karol Bezerra Thé2
ABSTRACT
Objective: To evaluate sexual experience and satisfaction in women
with fibromyalgia. Methods: Twenty women with fibromyalgia
were compared to 20 normal women using Beck depression
inventory and another questionnaire on sexual experience and
satisfaction. The following aspects were addressed: age, past
medical and surgical history, obstetric events, schooling, use of
medication, religion, marital status, and drug use. Statistical
analyses were performed using chi-squared test or Fisher’s test,
whenever appropriate, and Student’s t test. Results: The mean
age of women with fibromyalgia was lower than that of the control
group. There were more married women in the fibromyalgia group.
These patients showed greater modification in sexual activities
(p = 0.01); greater difficulty in having orgasm (p = 0.01) and were
more likely to masturbate (p = 0.053). Conclusions: Fibromyalgia
probably interferes in sexual function of women with this condition.
Further studies are necessary to evaluate this issue.
Keywords: Fibromyalgia; Sexual disfunction; Muscle diseases;
Rheumatologic diseases
RESUMO
Objetivo: Avaliar a experiência e a satisfação sexual em pacientes
portadoras de fibromialgia. Métodos: Foram avaliadas 20 pacientes
do sexo feminino, portadoras de fibromialgia e comparadas a 20
controles não portadoras de fibromialgia, por meio do inventário
de depressão de Beck e um questionário sobre experiência e
satisfação sexual. Foram questionadas quanto a idade,
antecedentes pessoais, passado obstétrico e mórbido,
escolaridade, ingestão de medicamentos, religião, estado civil e
uso de drogas. A análise estatística foi feita por meio dos testes
do qui quadrado e exato de Fisher, quando pertinente, e do teste t
de Student. Resultados: A média de idade das pacientes com
fibromialgia foi significativamente inferior à dos controles e no
grupo de portadoras de fibromialgia houve maior número de
mulheres casadas. Essas pacientes mostraram modificação da
atividade sexual em maior número que as do grupo controle
(p = 0,01), maior dificuldade em atingir o orgasmo (p = 0,044),
tendência maior à necessidade de masturbação (p = 0,053).
Conclusões: A fibromialgia provavelmente interfere na função
sexual de mulheres portadoras da afecção. Sugerem-se novas
pesquisas para estudo do assunto.
Descritores: Fibromialgia; Disfunção sexual; Doenças musculares;
Doenças reumatológicas
INTRODUCTION
Any problem that interferes in human sexual response
to erotic stimuli, be them psychological, biological or
social, is called sexual dysfunction.
The term female sexual dysfunction comprises
female orgasmic disorder, female sexual arousal
disorder and hypoactive sexual desire disorder.
However, even for the purpose of definition, all these
would be a “disease” if there were any suffering. We
often observe a “relative disease”, if this term may be
used. It refers to women whose sexual performance is
beyond what her partner expects, but there is no
suffering for her.
According to the National Health and Social Life
Survey(1), one third of women reports lack of sexual
interest, and approximately one fourth of women have
no orgasms. Slightly less than 20% of them present
impaired lubrication and over 20% finds sex unpleasant.
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The sum of these figures shows a major prevalence of
female sexual complaints.
Population studies demonstrated that sexual
dysfunction is more prevalent in women (43%) than in
men (31%) and it is associated with psychosocial factors,
such as race, schooling, use of medication and negative
sexual experiences(2-3). Community studies showed that
33-39% of women reported reduced libido(4), and that
was the major problem found in sexual therapy clinics(5-6).
Another study concluded that 50% of men and 77%
of women reported sexual difficulties that were not
dysfunctional (such as lack of interest or inability to
relax). Reported lack of sexual satisfaction correlated
more strongly with the number of difficulties than with
any other dysfunction(7).
Among the muscle and skeletal diseases,
fibromyalgia (FM) has stood out due to the high
prevalence in general practitioner and rheumatolologist
offices – 2.1% in private clinics(8), 5.7% in outpatients
units in private clinics(9), 5-8% in general hospitals(10)
and 14-20% in rheumatologic clinics(11-12). Fibromyalgia
is a chronic, non-inflammatory, painful syndrome
characterized by diffuse muscle and skeletal pain and
multiple tender points at palpation(13-14).
More recent studies performed in the United States
showed that 2% of population has fibromyalgia(15); in
that, 80 to 90% are females, aged 30-60 years. A
Brazilian study carried out in 2004 demonstrated the
prevalence of fibromyalgia was 2.5% in the population
of the city of Montes Claros(16).
Its etiology is very complex, and comprises alterations
of neurotransmitters involved in pain modulation,
thalamic perfusion disorders, alterations in the
hypothalamus-hypophysis-adrenal axis, as well as sleep
disorders(17). Apart from persistent pain, 90% of
patients complained of chronic fatigue(18), 25% of
patients presented major depression at diagnosis and
50% had a past history of depression(19).
It is known that fibromyalgia patients have a poorer
quality of life, which is considered inferior to that of
patients with other rheumatologic diseases, insulin-
dependent diabetes or chronic obstructive pulmonary
diseases(20). Preliminary data of a study demonstrated
that sexual satisfaction is significantly decreased in FM
as compared with normal individuals(21). In FM, the
use of antidepressants, as well as some psychological
factors, such as anxiety, depression, sleep disorders and
fatigue, may contribute to reduce the quality of sexual
life of these patients(21).
Although sexual satisfaction is an important
determinant in quality of life, there are few studies
assessing this aspect in fibromyalgia patients. This fact
motivated us to carry out the present investigation.
OBJECTIVE
To evaluate sexual experience and satisfaction in women
with fibromyalgia as compared with a control group.
METHODS
The study was carried out in the outpatients clinic of
the Discipline of Internal Medicine of the Medical
School - Universidade Federal de São Paulo.
Twenty female patients who met the criteria for
fibromyalgia established by the American Rheumatology
College(22) and 20 women without fibromyalgia, aged 18-
45 years were assessed. The patients and the controls
were asked about their age, medical and surgical history,
obstetric events, schooling, use of medication, religion,
marital status, and drug use.
The exclusion criteria were:
1. use of antidepressants and methyldopa;
2. menopause;
3. inflammatory rheumatologic diseases;
4. neurological, psychiatric, heart, pulmonary or
gynecologic diseases;
5. pregnancy;
6. women not sexually active;
7. moderate/severe depression;
8. alcoholism;
9. smokers;
10.schooling up to incomplete Junior School.
The Beck depression inventory(23-24) was applied to
rule out cases of moderate to severe depression, as well
as a questionnaire about sexual experience and
satisfaction, which was prepared based on the following
already validated questionnaires: Changes in Sexual
Functioning Questionnaire(25), Arizona Sexual
Experiences Scale(26), Psychotropic-related Sexual
Dysfunction Questionnaire(27).
All women signed an informed consent in order to
participate in the study.
The study was approved by the Research Ethics
Committee of the institution.
STATISTICAL ANALYSIS
In order to assess whether the explanatory variables
(marital status, schooling, etc.) were independent from
the groups (control and fibromyalgia), the chi-squared
test was used for 2x2 tables (+).
When the expected frequency in some cases was
smaller than 5, the Fisher’s exact test was used (++).
The significance level adopted was 0.05.
The same procedure was used to assess if the result
in each question (with two categories) was independent
from the groups (control and fibromyalgia).einstein. 2004; 2(3):177-81
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The Student’s t test was applied to assess if the
variables age and total score were, in average, the same
for both groups (control and fibromyalgia).
RESULTS
Table 1 shows the characteristics of the population
studied, their differences and significance level.
Table 1. Mean age and standard deviation in control group and fibromyalgia
group. Number of women and respective percentages with or without
husband in control group and fibromyalgia group. Schooling in control group
and fibromyalgia group. Religion in control group and fibromyalgia group
Characteristics Control Fibromyalgia p level
Age - mean and 28.5±10.3 34.9±6.6 0.03
standard deviation
Marital status
Married 13 (65%) 5 (25%) 0.011+
Unmarried 7 (35%) 15 (75%)
Schooling
Up to High School 9 (45%) 5 (25%) 0.185+
Higher education 11 (55%) 15 (75%)
Religion
Catholic 15 (75%) 15 (75%) 1+
Others 5 (25%) 5 (25%)
The mean age of patients in the fibromyalgia group
was 34.9 years and, in control group, 28.5 years, and
this difference was statistically significant (p = 0.03)
As to marital status, the majority of fibromyalgia
patients were married as compared with the control
group, and this data was statistically significant
(p = 0.011).
Both groups were homogeneous regarding schooling
and religion.
Concerning sexual satisfaction level, partner’s
satisfaction level, pain during intercourse, need to use
fetishes, report of premature orgasm, need for peculiar
positions or activities, feeling of blame, there were no
statistically significant differences between the two
groups (tables 2 and 3).
Table 2. Mean total score based on questionnaire about sexual experience
and satisfaction in fibromyalgia and control groups
Control Fibromyalgia p level
Mean and
Total score standard 33.1±8.3 36.1±9.7 0.30
deviation
Table 3. Sexual satisfaction level, partner’s satisfaction level, pain during
intercourse, need to use objects, images and fetishes, report of premature
orgasm, need for peculiar positions or activities during intercourse and
feeling of blame in control group and fibromyalgia group
Control Fibromyalgia p level
Sexual
satisfaction level Slightly intense 1 (5%) 0 1++
Very intense 19 (95%) 20 (100%)
Partner’s
satisfaction level Slightly intense 1 (5%) 3 (15%) 0.605++
Very intense 19 (95%) 17 (85%)
Pain No 19 (95%) 18 (90%) 1++
Yes 1 (5%) 2 (10%)
Fetishes No 17 (85%) 19 (95%) 0.605++
Yes 3 (15%) 1 (5%)
Premature orgasm No 20 (100%) 19 (95%) 1++
Yes 0 1 (5%)
Peculiar No 16 (80%) 18 (90%) 0.661++
activities Yes 4 (20%) 2 (10%)
Feeling of blame No 19 (95%) 17 (89.5%) 0.605++
Yes 1 (5%) 2 (10.5%)
Regarding need to masturbate, the fibromyalgia
group tended to masturbate more often than the
control group (p = 0.053) (table 4).
Table 4. Need to masturbate in control group and fibromyalgia group
Control Fibromyalgia p level
Masturbation No 15 (75%) 9 (45%) 0.053+
Yes 5 (25%) 11 (55%)
Fibromyalgia patients reported changes in sexual
activities (interest, arousal, orgasm) when compared
with the control group (p = 0.01) (table 5).
Table 5. Changes in sexual activity in control group and fibromyalgia group
Control Fibromyalgia p level
Changes in sexual
activities No 19 (95%) 9 (45%) 0.01+
4 Yes 1 (5%) 11 (55%)
Based on questions 1 to 14 of Beck’s inventory(23),
which were answered by fibromyalgia patients and the
control group, the following parameters were also
assessed: intensity of sexual desire, ability to be aroused,
ability to reach an orgasm, orgasm satisfaction level,
comfort with their sexual performance, frequency of
sexual activity, frequency of sexual thoughts, beginning
of sexual activities, vaginal lubrication, frequency of
arousal during sexual activities, frequency of orgasm,
level of pleasure during sexual activities, ability to
achieve orgasm, and frequency of painful penetration
or painful orgasms (table 6).
Considering these parameters, it was observed that
fibromyalgia patients presented lower ability to achieve
orgasm than the control group (p = 0.044) (table 7).
In the remaining items, there were no significant
differences among fibromyalgia patients and controls.einstein. 2004; 2(3):177-81
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Table 6. Parameters assessed according to Beck’s inventory
Questions Control Fibromyalgia p level
Q1 1-3 (strong) 15 (75%) 12 (60%) 0.311+
4-6 (weak) 5 (25%) 8 (40%)
Q2 1-3 (easy) 18 (90%) 14 (70%) 0.235++
4-6 (difficult) 2 (10%) 6 (30%)
Q3 1-3 (easy) 16 (80%) 13 (65%) 0.288+
4-6 (difficult) 4 (20%) 7 (35%)
Q4 1-3 (much) 19 (95%) 17 (85%) 0.605++
4-6 (little) 1 (5%) 3 (1%)
Q5 1-3 (much) 17 (85%) 15 (75%) 0.695++
4-6 (little) 3 (15%) 5 (25%)
Q6 1-3 (high) 16 (80%) 16 (80%) 1++
4-6 (low) 4 (20%) 4 (20%)
Q7 1-3 (high) 18 (90%) 15 (75%) 0.407++
4-6 (low) 2 (10%) 5 (25%)
Q8 1-3 (spontaneous) 20 (100%) 17(85%) 0.231++
4-6 (forced) 0 5 (15%)
Q9 1-3 (easy) 19 (95%) 18 (90%) 1++
4-6 (difficult) 1 (5%) 2 (10%)
Q10 1-3 (high) 19 (95%) 19 (95%) 1++
4-6 (low) 1 (5%) 1 (5%)
Q11 1-3 (high) 17 (85%) 14 (70%) 0.451++
4-6 (low) 3 (15%) 7 (30%)
Q12 1-3 (much) 20 (100%) 19 (95%) 1++
4-6 (little) 0 1 (5%)
Q14 1-3 (high) 20 (100%) 19 (95%) 1++
4-6 (low) 0 1 (5%)
Legend. Intensity of sexual desire (Q1), ability to be aroused (Q2), ability to
reach an orgasm 3), orgasm satisfaction level (Q4), comfort with their
sexual performance (Q5), frequency of sexual activity (Q6), frequency of
sexual thoughts (Q7), beginning of sexual activities (Q8), vaginal lubrication
level (Q9), frequency of arousal during sexual activities (Q10), frequency of
orgasm (Q11), level of pleasure (Q12), and frequency of painful penetration
or orgams (Q14) in control group and fibromyalgia group.
Table 7. Ability to achieve orgasm in control group and fibromyalgia group
Q13 Control Fibromyalgia p level
1-3 (much) 19 (95%) 13 (65%) 0.044++
4-6 (little) 1 (5%) 7 (65%)
DISCUSSION
Fibromyalgia is characterized by generalized pain in
the body, and it may be accompanied by fatigue, sleep
disorders, irritability and depression. The patients
present important worsening in quality of life, and they
are compared with patients suffering from chronic
obstructive pulmonary diseases(20).
This investigation might be considered a preliminary
study and its objective was to assess sexual satisfaction
in fibromyalgia patients as compared to women with
no fibromyalgia; all women were not in menopause, so
that hormone variations would not interfere. The Beck
inventory(23-24 ) was used, as well as another questionnaire
related to sexual experience and satisfaction(25-27).
Taking into account that the mean age of
fibromyalgia female patients is 43.2 years(16) in Brazil,
in this study the mean age found in both groups was
lower. Although there was a significant difference as
to age in both groups, there was a concern about
selecting women who were effectively not at
menopausal age; however, this finding was not valued
when interpreting the results.
On the other hand, the factor religion, which could
influence in sexual behavior of patients(28), was not
different between the two groups.
As to marital status, there was a statistically
significant difference between the groups in that most
fibromyalgia patients were married and the controls
that had partners were unmarried. Despite probable
emotional stability of marriage, these patients
presented higher non-satisfaction levels, as well as
changes in sexual activity as compared with the control
group. These might be due to pain, fatigue, irritability,
sleep disorders or even insatisfaction with the partner,
as provided in the literature(21).
The fibromyalgia patients showed a tendency to
need foreplay/masturbation, as compared with controls,
which was close to statistical significance. Since they
presented changes in sexual activity, they might
demand more foreplay/masturbation.
Regarding sexual desire, in the control group a
minority reported less intense desire, whereas in
fibromyalgia group, more subjects reported less desire.
This number did not show statistical significance, maybe
due to small sample of patients interviewed.
As to arousal level, fibromyalgia patients tended to
have more difficulties than the control group.
Concerning orgasm, it was more difficult for
fibromyalgia patients to reach orgasm, and they were
not able to reach whenever they wished, which was
statistically significant. One may speculate this fact
could be related to pain, fatigue or irritability.
Thus, we suggest other studies to address this issue,
comprising a larger sample in order to establish
definitive findings.
CONCLUSIONS
Fibromyalgia probably interferes with sexual
satisfaction level of female patients, since there were
changes in sexual activities regarding interest, arousal
and orgasm criteria, greater tendency to need
masturbation and less ability to reach an orgasm, when
compared with the control group of women with no
fibromyalgia.
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